Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

National Healthcare (NHC) EPS (Weighted Average and Diluted) (2016 - 2025)

National Healthcare (NHC) has disclosed EPS (Weighted Average and Diluted) for 16 consecutive years, with $1.58 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Weighted Average and Diluted) rose 315.79% year-over-year to $1.58, compared with a TTM value of $7.67 through Dec 2025, up 17.46%, and an annual FY2025 reading of $7.67, up 17.46% over the prior year.
  • EPS (Weighted Average and Diluted) was $1.58 for Q4 2025 at National Healthcare, down from $2.5 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $6.81 in Q2 2021 and bottomed at -$0.22 in Q3 2021.
  • Average EPS (Weighted Average and Diluted) over 5 years is $1.45, with a median of $1.23 recorded in 2021.
  • The sharpest move saw EPS (Weighted Average and Diluted) tumbled 126.19% in 2021, then surged 525.0% in 2023.
  • Year by year, EPS (Weighted Average and Diluted) stood at $1.02 in 2021, then crashed by 59.8% to $0.41 in 2022, then skyrocketed by 346.34% to $1.83 in 2023, then tumbled by 79.23% to $0.38 in 2024, then soared by 315.79% to $1.58 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for NHC at $1.58 in Q4 2025, $2.5 in Q3 2025, and $1.52 in Q2 2025.